Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Beauty Farm Medical & Health Industry EV-to-EBITDA?
Beauty Farm Medical & Health IndustryFRA:XC5 89 EV-to-EBITDA is 5.44 as of Aug. 22, 2026, which is 34% above its 10-year median of 4.06. GuruFocus rates FRA:XC5 with a GF Score™ of 89/100 and a GF Value™ of €3.00. The stock has 3 warning signs investors should review. Among 512 Healthcare Providers & Services companies, Beauty Farm Medical & Health Industry ranks better than 83.2% on this metric.
FRA:XC5's EV-to-EBITDA is ranked better than 83.2% of 512
companies
in the Healthcare Providers & Services industry
Industry Median: 10.6
vs FRA:XC5: 5.49
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Beauty Farm Medical & Health Industry (FRA:XC5) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beauty Farm Medical & Health Industry's PE Ratio (TTM) for today is calculated as:
Beauty Farm Medical & Health Industry's share price for today is €1.92.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beauty Farm Medical & Health Industry's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €0.166.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beauty Farm Medical & Health Industry EV-to-EBITDA Chart
For the Medical Care Facilities subindustry, Beauty Farm Medical & Health Industry's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beauty Farm Medical & Health Industry EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beauty Farm Medical & Health Industry's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Beauty Farm Medical & Health Industry's EV-to-EBITDA falls into.
Beauty Farm Medical & Health Industry's current Enterprise Value is €346.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beauty Farm Medical & Health Industry's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was €63.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beauty Farm Medical & Health Industry (FRA:XC5) has a EV-to-EBITDA of 5.44 as of Aug. 22, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Beauty Farm Medical & Health Industry. This is 34% above median its historical median of 4.06. Over the past decade, Beauty Farm Medical & Health Industry's EV-to-EBITDA has ranged from 1.67 to 13.33. According to the industry distribution chart, Beauty Farm Medical & Health Industry ranks #86 out of 512 companies in the Healthcare Providers & Services industry, placing it in the top 16.8%.
Is Beauty Farm Medical & Health Industry's EV-to-EBITDA too high?
Beauty Farm Medical & Health Industry's current EV-to-EBITDA of 5.44 is 34% above median its 10-year median of 4.06. Over the past 10 years, this metric has ranged from a low of 1.67 to a high of 13.33. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.60. Beauty Farm Medical & Health Industry's value of 5.44 is 48.7% below this industry median. Based on the distribution chart, Beauty Farm Medical & Health Industry ranks #86 out of 512 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Beauty Farm Medical & Health Industry has a GF Score™ of 89/100, reflecting its overall financial health beyond just this single metric.
How does Beauty Farm Medical & Health Industry's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Beauty Farm Medical & Health Industry ranks #86 out of 512 companies for EV-to-EBITDA. This places Beauty Farm Medical & Health Industry in the top 17% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 10.60. Beauty Farm Medical & Health Industry's value of 5.44 is 48.7% below this benchmark. Historically, Beauty Farm Medical & Health Industry's own EV-to-EBITDA has ranged from 1.67 to 13.33 over the past decade. While the company's 10-year median is 4.06 vs. the industry median of 10.60, Beauty Farm Medical & Health Industry has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.60, based on 512 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beauty Farm Medical & Health Industry's current EV-to-EBITDA of 5.44 is 48.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Beauty Farm Medical & Health Industry. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beauty Farm Medical & Health Industry's current EV-to-EBITDA is 5.44, which is 34% above median its own 10-year median of 4.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beauty Farm Medical & Health Industry stock overvalued right now?
Beauty Farm Medical & Health Industry (FRA:XC5) has a current EV-to-EBITDA of 5.44. The stock's GF Value™ is €3.00, compared to a current price of €1.92 — trading 36% below its estimated fair value. The current EV-to-EBITDA is 5.44, which is 34% above median its 10-year median of 4.06 and 48.7% below the Healthcare Providers & Services industry median of 10.60. Beauty Farm Medical & Health Industry's overall GF Score™ is 89/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Beauty Farm Medical & Health Industry (FRA:XC5), the current EV-to-EBITDA is 5.44 as of Aug. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beauty Farm Medical & Health Industry (FRA:XC5) Overvalued in 2026?
Based on GuruFocus' analysis, Beauty Farm Medical & Health Industry stock appears to be undervalued.
The current stock price of €1.92 is trading 36% below its estimated GF Value™ of €3.00.
Key valuation signals for FRA:XC5:
EV-to-EBITDA: 5.44 (34% above median its 10-year median of 4.06)
GF Value™: €3.00 vs. price of €1.92 (36% below fair value)
Industry Position: 48.7% below the Healthcare Providers & Services median (#86 of 512)
No single metric tells the full story. See the FRA:XC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beauty Farm Medical & Health Industry Inc. provides beauty and wellness services in the People's Republic of China. It offers high-quality beauty and wellness services, aesthetic medical services, and subhealth medical services according to customers' individual needs. The company offers its products and services through brands such as Beauty Farm, Palaispa, Naturade, Cellcare, and Neology.
89GF Score
Get the complete analysis for FRA:XC5
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:XC5 has been successfully added to your 
